UNJHAFORPharmaceuticals
Unjha Formulations Ltd — Quarterly Results & Earnings
₹20.29
-1.10%
Profit Growth YoY845.45%Latest quarter
Sales Growth YoY13.49%Latest quarter
Sales CAGR 5Y5.53%5 year compound
Profit CAGR 5Y5.75%5 year compound
📋
Quarterly Performance
YoY Profit Growth+845.45%
🔥 Exceptional growth
YoY Sales Growth+13.49%
✅ Strong growth
OPM 5Y Average
2.84%Operating profit margin
EPS Growth 5Y
5.75%Interest Coverage
N/AHigher = safer debt servicing
ROE
13.97%ROCE
18.06%💡
Growth Analysis
Unjha Formulations Ltd reported YoY profit growth of 845.45% and revenue growth of 13.49% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 5.53% and profits at 5.75% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Unjha Formulations Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.